NCT04764968View on ClinicalTrials.gov

Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 28, 2022

Conditions
Type 1 DiabetesHypoglycemia
Interventions
DRUG

Dasiglucagon

Abdominal s.c. administration using a multi-dose reusable pen injector

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER